Alpha Tau Medical Ltd. (DRTS)
Last updated: 2026-10-20 17:14:00. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Summary
Alpha Tau Medical Ltd. (DRTS) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $13.10, with a market capitalization of $1.14B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $3.43 to $15.79. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$1.14B | |
$12.61 | |
$20.65 | |
$1.75 | |
$12.62 | |
284.83K | |
545.83K | |
-- | |
$15.79 | |
$3.43 | |
-- | |
-- |
Alpha Tau Medical Ltd. (DRTS) Stock Price Today
Alpha Tau Medical Ltd. (DRTS) is currently trading at $13.10 as of 2026-10-20 17:13:00, up 3.80% ($0.48) from the previous close of $12.62
During today's regular trading session, DRTS has traded between $1.75 and $20.65, with a trading volume of 284.83K shares. The current price is near the middle of today's range.
Alpha Tau Medical Ltd. (DRTS) 7-Day Stock Price Change
Over the past seven days, Alpha Tau Medical Ltd. (DRTS) moved from $14.41 to $13.10, representing a decline of 9.10% ($1.31).
The stock traded between $11.99 and $14.50 during the period. The latest price is near the middle of the 7-day range, indicating strong downward.
The average daily volume was 520.64 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
DRTS 52-Week Price Position
Position in Range: 78.2%
DRTS is currently trading at $13.10, placing it 78.2% of the way from its 52-week low of $3.43 to its 52-week high of $15.79. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Alpha Tau Medical Ltd. (DRTS)?
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as a localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company has active clinical programs targeting a range of different tumor types, such as head and neck cancer, pancreatic cancer, brain cancer, liver metastases, lung cancer, and prostate cancer. Geographically, it operates in Israel, United States, and Japan with the majority of the revenue generated from Israel.
Alpha Tau Medical Ltd. Information
| Employees | 121 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Alpha Tau Medical Ltd. (DRTS) Stock on MEXC
Eligible investors can buy real shares of Alpha Tau Medical Ltd. (DRTS) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Alpha Tau Medical Ltd. (DRTS) stock price today?
2.Is DRTS stock going up or down today?
3.What is DRTS pre-market price?
4.What is DRTS after-hours price?
5.Is DRTS stock trading now?
6.Where does DRTS sit relative to its 52-week high and low?
7.What sector is Alpha Tau Medical Ltd. in?
8.What is Alpha Tau Medical Ltd.'s market capitalization and where is it listed?
9.How is DRTS valued in terms of P/E ratio and EPS?
10.Does Alpha Tau Medical Ltd. pay a dividend?
Explore More US Stocks
Search Stocks
DRTS Stock Calculator
Estimate the value between DRTS shares and USD.
DRTS Shares to USD
1.00 DRTS shares = 13.099 USD
Calculations are estimates based on the latest available price and are for reference only.


